Get started
Author

C. Miner

Observed names: C Miner, C. M. Miner
OpenAlex ID: A5111761365
Negative symptoms in patients with Alzheimer's disease
1994 · I. Galynker, D. Roane, et al. · Biological Psychiatry · 7
Efficacy of intermittent fluoxetine dosing in premenstrual dysphoric disorder (PMDD)
2001 · L. Cohen, C. Miner, et al. · European Neuropsychopharmacology · 6
P.1.204 Duloxetine vs placebo in the prevention of relapse of major depressive disorder
2003 · M. Detke, I. Gilaberte, et al. · European Neuropsychopharmacology · 5
Negative symptoms in patients with basal ganglia strokes
1994 · I. Galynker, I. Levinson, et al. · Biological Psychiatry · 5
Predictors of response to luteal phase fluoxetine treatment of PMDD
2002 · L. Cohen, S. Davis, et al. · European Neuropsychopharmacology · 4
Hypofrontality in major depressive disorder: Relationship to psychiatric symptoms
1996 · I. Galynker, J. Cai, et al. · Biological Psychiatry · 3
Pmh6 Impact of Comorbidities on Antidepressant Initiation: Duloxetine, Venlafaxine, and Escitalopram Versus Other Ssris
2009 · X Liu, Y Chen, et al. · Value in Health · 2
PDF
Clinical significance of negative symptoms in stroke patients
1995 · I. Galynker, J. Rosenblum, et al. · Biological Psychiatry · 2
Tc-99m HMPAO brain SPECT in stroke patients with negative symptoms
1995 · I. Galynker, C. Ieronimo, et al. · Biological Psychiatry · 1
Fluoxetine in relapse prevention of PTSD
2003 · E. B. Brown, A. Prakash, et al. · The British Journal of Psychiatry
PDF
Long-term safety upon switching from daily SSRIs to fluoxetine once-weekly
2002 · E. Brown, C. Miner, et al. · European Neuropsychopharmacology
Predictors of improvement: Switching from daily SSRIs to fluoxetine once-weekly
2002 · E. Brown, C. Miner, et al. · European Neuropsychopharmacology
Recurrence of premenstrual dysphoric disorder (PMDD) symptoms after fluoxetine treatment discontinuation
2002 · E. Brown, T. Pearlstein, et al. · European Neuropsychopharmacology
Luteal phase treatment of fluoxetine in premenstrual dysphoric disorder (PMDD): Effect on sexual functioning
2001 · S. Kornstein, C. Miner, et al. · European Neuropsychopharmacology
Relapse of premenstrual dysphoric disorder (PMDD) after cessation of luteal phase fluoxetine treatment
2001 · T. Pearlstein, C. Miner, et al. · European Neuropsychopharmacology
Overlap of negative and depressive symptoms in non-schizophrenic subjects
1996 · I. Galynker, J. Cai, et al. · Biological Psychiatry
A naturalistic study of methylphenidate in the treatment of negative symptoms in dementias
1995 · I. Galynker, C. Ieronimo, et al. · Biological Psychiatry
Works count: 17
Citation count: 35
H-index: 4
I10-index:
Year
Topic
Type